Arrowhead Pharmaceuticals strikes a $130M+ deal with Sanofi for plozasiran in Greater China, targeting high triglyceride ...

Sanofi is handing over $130 million upfront for the China rights to Arrowhead Pharmaceuticals’ rare metabolic disease ...

After Travis Kelce shared highlights of his offseason with Taylor Swift, he cheekily reacted to one of the best moments, ...

A neighborhood just outside of Sioux Falls city limits has been continuing to deal with people trying to take shortcuts ...

Clark Hunt’s latest comments have Chiefs fans holding their breath. The Kansas City owner confirmed the team is weighing two ...

The drama swirling around where the Kansas City Chiefs and Royals will play in 2031 and beyond has been going on for more ...

On Monday, Chiefs Kingdom received a new update from owner Clark Hunt, who described the situation as having "two great ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is a biotechnology company specializing in RNA interference (RNAi) therapeutics ...

Friday’s Kansas City Chiefs training camp practice gets underway at 9:15 a.m. (Arrowhead Time) on the practice fields ...

The Arrowhead School Board unanimously voted to update its anti-harassment policy, removing the word "gender" and replacing ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $100 million milestone payment from Sarepta Therapeutics (NASDAQ: SRPT). The milestone was triggered when Arrowhead ...

Sarepta Therapeutics' licensing partner Arrowhead Pharmaceuticals said on Wednesday it expects to receive near-term milestone ...